These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3836113)
21. Central effects following repeated treatment with antidepressant drugs. Maj J Pol J Pharmacol Pharm; 1984; 36(2-3):87-99. PubMed ID: 6089162 [TBL] [Abstract][Full Text] [Related]
22. Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist. Simiand J; Keane PE; Barnouin MC; Keane M; Soubrié P; Le Fur G Fundam Clin Pharmacol; 1993; 7(8):413-27. PubMed ID: 7904976 [TBL] [Abstract][Full Text] [Related]
23. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative. Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290 [TBL] [Abstract][Full Text] [Related]
24. Effects of dexfenfluramine on dopamine dependent behaviours in rats. Thorat VM; Gaonkar RK; Bhosale KB; Balsara JJ Indian J Physiol Pharmacol; 2005 Jan; 49(1):39-48. PubMed ID: 15881857 [TBL] [Abstract][Full Text] [Related]
25. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia. Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322 [TBL] [Abstract][Full Text] [Related]
26. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions. Arnt J; Hyttel J; Overø KF Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152 [TBL] [Abstract][Full Text] [Related]
27. Possible involvement of the dopaminergic system in the mode of action of the potential antidepressant trazium esilate. Gyertyán I; Petöcz L; Bajnógel J; Szücs Z; Hegedüs M; Gyüre K; Gacsályi I; Krizsán D; Fekete MI Arzneimittelforschung; 1989 Jul; 39(7):775-81. PubMed ID: 2551306 [TBL] [Abstract][Full Text] [Related]
28. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent]. Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774 [TBL] [Abstract][Full Text] [Related]
29. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity. Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184 [TBL] [Abstract][Full Text] [Related]
30. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist. Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225 [TBL] [Abstract][Full Text] [Related]
31. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist. Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012 [TBL] [Abstract][Full Text] [Related]
32. Serotonin-2 receptor-mediated regulation of release of acetylcholine by minaprine in cholinergic nerve terminal of hippocampus of rat. Muramatsu M; Tamaki-Ohashi J; Usuki C; Araki H; Aihara H Neuropharmacology; 1988 Jun; 27(6):603-9. PubMed ID: 3419543 [TBL] [Abstract][Full Text] [Related]
33. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870 [TBL] [Abstract][Full Text] [Related]
34. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist. Bartoszyk GD; Harting J; Minck KO J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454 [TBL] [Abstract][Full Text] [Related]
35. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat. Mignon L; Wolf WA Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404 [TBL] [Abstract][Full Text] [Related]
36. Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice. Sansone M; Battaglia M; Vetulani J Pol J Pharmacol; 1995; 47(1):69-73. PubMed ID: 7550552 [TBL] [Abstract][Full Text] [Related]
37. Dose-dependent response of central dopaminergic systems to buspirone in mice. Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Gursale SC; Balsara JJ Indian J Exp Biol; 2008 Oct; 46(10):704-14. PubMed ID: 19024168 [TBL] [Abstract][Full Text] [Related]
38. Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats. Balsara JJ; Jadhav SA; Gaonkar RK; Gaikwad RV; Jadhav JH Psychopharmacology (Berl); 2005 May; 179(3):597-605. PubMed ID: 15614572 [TBL] [Abstract][Full Text] [Related]
39. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. Sprah L; Zivin M; Sket D J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846 [TBL] [Abstract][Full Text] [Related]
40. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models. Baizman ER; Ezrin AM; Ferrari RA; Luttinger D J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]